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Many clinical trials are beginning to assess the effectiveness of compounds known
to regulate autophagy in patients receiving anti-cancer chemotherapy. However,
autophagy inhibition, through exogenous inhibitors, or activation, through starvation,
has revealed conflicting roles in cancer management and chemotherapeutic outcome.
This study aimed to assess the effect of amino acid starvation on doxorubicin-treated
breast cancer cells by assessing the roles of autophagy and apoptosis. An in vitro breast
cancer model consisting of the normal breast epithelial MCF12A and the metastatic
breast cancer MDAMB231 cells was used. Apoptotic and autophagic parameters were
assessed following doxorubicin treatments, alone or in combination with bafilomycin,
ATG5 siRNA or amino acid starvation. Inhibition of autophagy, through ATG5 siRNA
or bafilomycin treatment, increased caspase activity and intracellular doxorubicin
concentrations in MCF12A and MDAMB231 cells during doxorubicin treatment. While
amino acid starvation increased autophagic activity and decreased caspase activity and
intracellular doxorubicin concentrations in MCF12A cells, no changes in autophagic
parameters or caspase activity were observed in MDAMB231 cells. Our in vivo data
showed that 24 h protein starvation during high dose doxorubicin treatment resulted
in increased survival of tumor-bearing GFP-LC3 mice. Results from this study suggest
that short term starvation during doxorubicin chemotherapy may be a realistic avenue
for adjuvant therapy, especially with regards to the protection of non-cancerous cells.
More research is however, needed to fully understand the regulation of autophagic flux
during starvation.
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INTRODUCTION
Solid tumors make up the majority of all human cancers. Once solid neoplasms become established
they can partially adapt to local micro-environmental shortages in nutrient supply by increasing
autophagy (Mathew et al., 2007). Cellular nutritional status is closely associated with autophagy
and several dietary factors are known to promote autophagy induction, one of the most effective
being the restriction of dietary calorie intake. While dietary habits are also linked to cancer risk and
progression (Popkin, 2007), caloric restriction exhibits a promising ability to extend the lifespan
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of patients (Heilbronn and Ravussin, 2005) and facilitate
tumor suppression (Kritchevsky, 2003). The application of short
term starvation protocols in patients receiving high doses of
chemotherapy has proven successful in reducing side effects
in these patients (Safdie et al., 2009). In a cell culture and
neuroblastoma mouse xenograft model, normal cells placed
on a similar starvation protocol were shown to benefit from
differential protection compared to cancer cells during high
dose chemotherapy regimens (Raffaghello et al., 2008). Mice
starved for 48 h had reduced chemotoxicity following high
dose treatment, whereas mice fed ad libitum were 50% more
likely to die. Tumor cell death was not compromised by the
starvation protocol. The underlying mechanisms responsible
for this differential protection of non-cancer cells are not yet
fully understood.
Autophagy has been reported to confer resistance onto
apoptosis-deficient cancer cells under metabolic stress by
delaying the onset of necrotic cell death (Degenhardt et al.,
2006; Sutton et al., 2019). Similarly, autophagy has also been
reported to protect Caco-2 cells following exposure to toxins
released by Vibrio cholera by engulfing and sequestering the
toxins in lysosomal compartments (Gutierrez et al., 2007).
More recently, high mobility group box 1 (HMGB1) release
following chemotherapy-induced damage to leukemia cells
caused a protective autophagy response (Liu et al., 2011a),
strengthening the possibility that damage-associated molecular
pattern molecule (DAMP) release during chemotherapy can
increase autophagy to grant a defensive reaction (Liu et al.,
2011b). In this way, damage caused by cytotoxic agents could
directly result in an increased autophagic response.
Based on the premise that autophagy can promote tumor
survival, it is believed that targeted and specific inhibition
of autophagy could be a promising therapeutic avenue.
Several in vitro studies have illustrated the potential of
class-III phosphatidylinositol-3-kinase inhibitors such as 3-
methyladenine, which prevent the formation of autophagosomes,
in cancer therapy (Kanzawa et al., 2004). However, while
starvation of a cervical cancer cell line resulted in apoptosis
in the presence of this inhibitor (Boya et al., 2005), 3-
methyladinine prevented tamoxifen-induced apoptosis in breast
cancer cells (Bursch et al., 1996). Agents such as bafilomycin A1
(Baf), hydroxychloroquine and monensin (all of which prevent
lysosomal fusion with autophagosomes) triggered apoptosis
in HeLa cells during nutrient depletion (Boya et al., 2005),
whilst Baf was also able to impede the protective effect of
autophagy in several cancer lines undergoing radiation therapy
(Paglin et al., 2001).
Even though Doxorubicin (Dox) is possibly the most effective
anti-cancer agent available to date, it is also cytotoxic and can
lead to cardiotoxicity as a result of its cumulative and dose-
dependent effects (Swain et al., 2003). More effective strategies
are needed to increase efficacy and protect non-cancer cells from
off-target cytotoxicity. It is now also known that many anti-
cancer agents and therapies increase autophagy levels in treated
cancer cells at certain doses (Wu et al., 2006; Park et al., 2008).
Transient, rapid and unpredictable alterations in autophagic flux
could modify the way tumors respond to chemotherapy and
supposedly interfere with or even augment therapy outcomes
in unexpected ways. This study therefore aimed to establish
the relative sensitivity of MDAMB231 and MCF12A cells to
Doxorubicin, followed by the assessment of autophagy, apoptosis
and the cell cycle. Furthermore, the efficiency of amino acid
starvation in combination with Dox treatment was also assessed.
Finally, a tumor-bearing mouse model was employed to assess
whether protein starvation can sensitize tumors to Dox therapy.
MATERIALS AND METHODS
Cell Culture
Experiments were performed using two cell lines: the human
metastatic mammary carcinoma cell line, MDAMB231, obtained
from American Type Culture Collection (Rockville, MD,
United States) and the human non-tumourigenic breast epithelial
cell line, MCF12A, obtained from the University of Cape Town.
The MCF7 cell line, used in selected experiments, was a donation
from the University of the Western Cape.
During routine maintenance, cells were grown as monolayers
in Glutamax-Dulbecco Modified Eagles Medium (DMEM; Celtic
Molecular Diagnostics, Cape Town, South Africa) supplemented
with 10% fetal bovine serum (FBS; Sigma Chemical Co., St
Louis, MO, United States) at 37◦C in a humidified atmosphere
with 5% CO2. MCF12A cell’s growth medium was supplemented
with Hams F12 medium (1:1), 0.5 µg/ml hydrocortisone,
10 µg/ml insulin and 20 ng/ml epithelial growth factor (EGF). All
supplements were obtained from Sigma Chemical Co., St Louis,
MO, United States.
Cells were first allowed to proliferate in T75 flasks (75 cm2
flasks, Greiner Bio One, Germany) until confluency of
approximately 80%, where after cells were subcultured into
appropriate treatment plates or dishes. All experiments were
performed using exponentially growing cells.
Drug Treatments
The following groups were used for the purpose of this study: (i) a
control group, (ii) a Dox group, (iii) a siRNA control group, (iv) a
siRNA control Dox group, (v) an ATG5 siRNA Dox group (ATG5
siRNA transfection 24 h prior to Dox treatment for 24 h), (vi) a
Baf group and (vii) a Baf Dox group (Baf treatment 6 h prior to
analysis, Dox treatment for 24 h).
Dox hydrochloride (D1515, Sigma Chemical Co., St Louis,
MO, United States) stock solutions, as well as further dilutions
to a concentration of 1 µM, was prepared in amino acid free
medium. Bafilomycin (B1793, Sigma Chemical Co., St Louis, MO,
United States) was dissolved in dimethyl sulfoxide (DMSO) to
prepare stock solutions, while further dilutions to a concentration
of 10 nM was performed in amino acid free medium. Based
on previous experience (unpublished results), DMSO at this
concentration (0.00625%) does not have any cytotoxic effects on
MCF12A and MDAMB231 cells. For the siRNA group, please
see the next section. For experiments conducted in the absence
of amino acids, amino acid free culture medium (Highveld
Biological Pty.) was used.
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ATG5 siRNA Transfection
Cells were transfected using a reverse transcription protocol
into 60 mm petri dishes. ATG5 siRNA duplex (20 pmol, Cell
Signaling, Danvers, MA, United States, lSilence R© Atg5 siRNA I
#6345) was diluted into 250 µl transfection medium (containing
no antibiotics or serum), where after 2 µl of LipofectamineTM
RNAiMAX (13778075; InvitrogenTM, United States) was added.
A volume of 250 µl from this suspension was added to each
petri dish and allowed to incubate for 20 min. MCF12A cells
(100 000) or MDAMB231 cells (80 000) were then plated into
the culture dishes containing the RNAi duplex-Lipofectamine
RNAiMAX complexes to have a final volume of 2 ml and
gently mixed. Cells were incubated at 37◦C until ready to treat,
48 h later. Stealth RNAi (STEALTH RNAI NEG CTL MED
GC, 12935300; InvitrogenTM, United States) was used as a
negative control.
Caspase 3/7 Activity
Caspase-3/7 activity was measured using the Caspase-
Glo R© 3/7 assay (Promega, Madison, WI, United States).
MCF12A cells (15 000) or MDAMB231 cells (10 000) were
plated 48 h prior to treatment in white-walled 96-well
plates in 100 µl culture medium. In experiments where
transfection was necessary, cells were reverse transfected
during plating. Following treatment, 100 µl (1:1) of Caspase-
Glo R© 3/7 working reagent was added to each well, and the
plates mixed at 500 rpm for 30 s. The plates were then
incubated at 22◦C for 1 h in the dark and the luminescence
measured in a luminometer (GloMaxTM 96 Microplate
Luminometer, Promega).
Trypan Blue Assay
Trypan blue cell viability was assessed using the CountessTM
Automated Cell Counter (Invitrogen, United States). MCF12A
cells (100 000) or MDAMB231 cells (80 000) were plated
into 60 mm culture dishes 48 h prior to treatment. Following
treatment, cells were trypsinised and pelleted, where after a 10 µl
cell suspension was mixed with 10 µl 0.4% trypan blue and 10 µl
loaded into a CountessTM chamber slide. Trypan blue positivity
was calculated automatically and expressed as the total number
of trypan blue positive cells, total number of trypan blue negative
cells and absolute total cell number.
Western Blotting
Following treatment, plates containing cell monolayers were
rinsed three times in 5 ml pre-lysis buffer (20 mM Tris-
HCl, pH 7.4, 137 mM NaCl, 1 mM CaCl2, 1 mM MgCl2
and 0.1 mM sodium orthovanadate). Total cell protein was
extracted by incubating cells on ice for 10 min in 1 ml
radioimmunoprecipitation (RIPA, pH 7.4) buffer containing:
2.5 mM Tris–HCl, 1 mM EDTA, 50 mM NaF, 50 mM NaPPi,
1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride
(PMSF), 1 mM benzamidine, 4 mg/ml SBTI, 10 mg/ml leupeptin,
1% NP40, 0.1% SDS and 0.5% Na-deoxycholate. Adherent cells
were harvested from culture dishes by scraping, where after
whole cell lysates were sonicated and centrifuged (8,000 rpm for
10 min; 4◦C). Protein content was quantified using the Bradford
protein determination method (Bradford, 1976) directly before
preparation of cell lysates.
Fourty microgram protein extracts were prepared in Laemmli
sample buffer and boiled for 5 min (95◦C) prior to their
separation on 12% polyacrylamide gels for LC3 II and caspase
3 and 10% polyacrylamide gels for beclin 1 by sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Gels
were run for 60 min at 130 V (constant) and 400 mA (Mini
Protean System, Bio-Rad, United States). Following SDS-PAGE,
proteins were transferred to polyvinylidine fluoride (PVDF)
membranes (Immobilon, Millipore, United States) using a
semi-dry electrotransfer system (Bio-Rad, United States) for
60 min at 15 V and 0.5 A. To prevent non-specific binding,
membranes were blocked in 5% (w/v) fat-free milk in 0.1% Tris
Buffered Saline-Tween20 (TBS-T) for 2 h at room temperature
with gentle agitation. Membranes were incubated with LC3
primary antibody, caspase 3 primary antibody or beclin 1
primary antibody (all 1:1000; Cell Signaling, Danvers, MA,
United States) overnight at 4◦C. Goat anti-rabbit (Amersham
Biosciences, United Kingdom, and Dako Cytomation, Denmark)
horseradish peroxidase (HRP)-conjugated secondary antibody
was added and incubated for 1 h at room temperature
with gentle agitation. Antibodies were detected with the
LumiGLO ReserveTM chemiluminescent substrate kit (KPL,
Inc., United States) and exposed to autoradiography film
(Hyperfilm, Amersham Biosciences, United Kingdom). Exposed
bands were visualized and quantified by densitometry using
the UNSCAN-IT© densitometry software (Silk Scientific
Corporation, Utah, United States). All bands were expressed
as optical density readings relative to a control present
on the same blot.
Cell Cycle Analysis
Flow cytometric analysis of the cell cycle was performed using
the CycleTESTTM PLUS DNA Reagent kit (Becton Dickinson,
San Jose, CA, United States). MCF12A cells (200 000) or
MDAMB231 cells (150 000) were plated in T25 culture
flasks 48 h prior to treatment. Prior to analysis, cells were
trypsinised and the cell suspensions centrifuged at 400 × g for
5 min at room temperature. Cells were washed in phosphate
buffered saline (PBS) and 250 µl trypsin buffer was added
to each tube and allowed to react for 10 min at room
temperature. Thereafter, 200 µl of trypsin inhibitor and RNase
buffer was added for 10 min, followed by 200 µl ice cold
propidium iodide stain solution on ice in the dark for a further
10 min. Samples were filtered through a 50 µm nylon mesh.
Sample fluorescence was acquired using flow cytometry within
30 min and results obtained with ModFit LT software (Verity
software house, Inc., ME, United States.) on a BD FACSAria
I. At least 30 000 list-mode data events were acquired for
each sample. A 585/42 bandpass filter was used to analyze
light emitted between 564 and 606 nm by stained cells.
ModFit LT software was used to determine the percentage
of cells in the g0/g1, s and g2/m phases. Mean percentages
from three independent experiments were used to perform
statistical comparisons.
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Hoechst Nuclear Staining (Analysis of
Pyknosis and Karyorrhexis)
To differentiate between normal nuclear morphology and
apoptosis, characterized as nuclear condensation and
fragmentation, staining with the DNA dye Hoechst 33342
(Sigma Chemical Co., St Louis, MO, United States) was
employed. MDAMB2321, MCF12A and MCF7 cells were
cultured and maintained as described previously, where
after 60 000 MCF12A cells, 45 000 MDAMB231 cells and
45 000 MCF7 cells were plated into 35 mm culture dishes
containing coverslips 48 h prior to treatment. Thereafter,
the coverslips were removed, placed over glass slides, and
washed with 100 µl ice cold PBS. The coverslips were treated
with 500 µl ice cold acetone:methanol (1:1) and incubated
at 4◦C for 10 min. The fixative was removed and coverslips
washed with PBS. A volume of 100 µl Hoechst in a 1:200
dilution (50 µg/ml) in sterile PBS was added directly onto the
coverslips and incubated in the dark for 10 min. Coverslips
were washed with PBS at room temperature before being
mounted. Cells were viewed immediately using a Nikon E-400
fluorescence microscope (Nikon Microscopes, Kobe, Japan)
and images acquired using a Nikon DMX1200 color digital
camera (Nikon Microscopes, Kobe, Japan) with ACT-I software.
Three independent experiments were conducted and four
representative regions of each condition were acquired per
experiment. At least 200 cells were analyzed per region. For
each image, the number of condensed/fragmented nuclei was
counted and expressed as a percentage of the total number of
nuclei counted. In this manner, the percentage apoptosis was
determined for each experimental condition.
Dox and Lysosomal-Associated
Membrane 2A (LAMP-2A) Fluorescence
Imaging
MCF12A cells (12 000) and MDAMB231 cells (10 000) were
seeded into 8-well NuncTM chambered plates (Nalge Nunc,
Rochester, NY, United States). Cell monolayers were washed
three times with sterile PBS before being fixed and permeabilised
with an ice cold 1:1 methanol:acetone mixture for 10 min at
4◦C. After being left to air dry for 20 min in the dark, cells
were washed three times in sterile PBS and non-specific binding
blocked by incubation with 5% donkey serum for 20 min. Cells
were then incubated with anti-LAMP-2A primary antibody (Cell
Signaling, MA, United States) for 90 min. Thereafter, a FITC-
bound secondary antibody was added for 30 min and nuclei
counter-stained using Hoechst 33342 (10 mg/ml in a 1:200
dilution) for 10 min at 4◦C. No additional steps were required
for visualization of Dox since the compound exhibits strong
autofluorescence. Images were acquired with an Olympus Cell∧R
fluorescence 1X81 inverted microscope (Olympus Biosystems,
Germany) using an F-view II camera for image acquisition and
Cell∧R software for image processing.
LysotrackerTM (Flow Cytometry)
MCF12A cells (200 000) or MDAMB231 or MCF7 cells
(150 000) were plated into T25 culture flasks 48 h prior
to treatment. Prior to analysis, cells were trypsinised and
the cell suspensions centrifuged at 400 × g for 5 min at
room temperature. Cells were then washed once in PBS.
LysotrackerTM (InvitrogenTM, United States) was prepared in
PBS (1:10 000) immediately before use. All treated samples
were split 1:1, where after cell suspensions were centrifuged
at 400 × g for 5 min at room temperature. For each sample,
one cell suspension was stained while the other was left
unstained. For staining, the pellets were resuspended in 250 µl
fresh LysotrackerTM/PBS and incubated for 10 min at room
temperature before analysis using flow cytometry (BD FACSAria
I). At least 10,000 cells were collected using a 488 nm laser
and 610LP, 616/23BP emission filters. Values obtained for the
unstained samples were then subtracted from those obtained for
the stained samples.
Tumor Establishment and Animal
Protocols
The protocols in this study were carried out according to
the guidelines for the care and use of laboratory animals
implemented at Stellenbosch University (2009B02004). Eight
week-old female C57BL6 mice (Stellenbosch University
animal facility) or GFP-LC3 mice (kindly donated by Noboru
Mizushima, Department of Cell Biology, National Institute for
Basic Biology, Okazaki, Japan) were used in this study. The mice
were maintained on standard chow diet and tap water before
beginning the experiment. Mice were inoculated subcutaneously
on the left pad of the fourth mammary gland with 200 µl of
2.5× 105 E0771 cells suspended in Hanks Balanced Salt Solution
(Sigma Chemical Co., St Louis, MO, United States), using a
23-gauge needle. This protocol was adapted from Ewens et al.
(2006). Small tumors were evident by days 12–14 and grew to
reach approximately 230 mm2 in volume by day 33.
Drug Preparation and Administration
Doxorubicin hydrochloride (D1515, Sigma Chemical Co., St
Louis, MO, United States) was dissolved in Hanks Balanced Salt
Solution (Sigma Chemical Co., St Louis, MO, United States).
Volumes were prepared to reflect the exact concentration
required per kilogram (kg) of body weight for each mouse
on the day of injection. Doxorubicin treatment was initiated
on day 33 and was administered twice over a period 3 days
(i.e., on day 33 and day 35) by means of i.p. injections.
Mice were restrained by the scruff method and 100 µl drug
suspensions were injected into the right caudal thigh (avoiding
the femur and sciatic nerve) of each mouse using a 23-gauge
needle. Control mice were injected with the vehicle only.
Immediately following doxorubicin treatment, tumor-bearing
mice were placed on either a control diet containing protein
(Research Diets, Inc., New Brunswick, NJ, United States) or
a diet free of protein (Research Diets, Inc., New Brunswick,
NJ, United States) for a total of 24 h. These two diets were
isocaloric. For the 24 h period in between interventions, mice
received the control diet containing protein. Tumor size was
monitored every 2 to 3 days by making measurements in
two perpendicular dimensions parallel with the surface of the
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mice using digital calipers. The body weight of the mice
was monitored twice weekly. To assess intratumour caspase
cleavage, FLIVOTM in vivo apoptosis tracers (Immunochemistry
Technologies LLC, MN, United States) were used. The SR
FLIVOTM red dye was prepared according to the manufacturer’s
protocol and 100 µl was injected into the tail vein of mice after
appropriate treatments were completed. After 1 h, whole tumors
were excised, digested and analyzed using flow cytometry on
the BD FACSAria I.
Statistical Analysis
Data from at least three independent experiments were analyzed.
Significant differences between time points and treatment groups
were analyzed using either a one or two-way analysis of variance
(ANOVA), together with a Bonferonni post hoc test. All statistical
analyses were performed using Graphpad Prism version 5.01
(Graphpad Software, Inc, San Diego, CA, United States). All
values are presented as means ± standard error of the mean
(SEM), and the minimum level of significance was accepted as
p < 0.05.
RESULTS
MDAMB231 Cells Are More Resistant to
Dox Treatment Compared to MCF12A
Cells
Dox treatment significantly increased apoptosis in MCF12A
cells (Figure 1A). Approximately 15% of MCF12A cells
presented with morphological changes to their nuclei
(Figures 1A,B). MDAMB231 cells on the other hand displayed
a relative resistance to apoptosis following treatment with Dox
(Figure 1C). A very small, but statistically significant percentage
of MDAMB231 cell’s nuclei presented with morphological
changes characteristic of apoptosis (Figures 1C,D).
Dox Treatment Increased LC3 II, but Not
Beclin 1 Levels in MCF12A and
MDAMB231 Cells
Both MCF12A and MDAMB231 cells responded to the presence
of Dox by increasing LC3 II protein levels (Figure 2). Although
FIGURE 1 | Percentage apoptotic cells in MCF12A and MDAMB231 cultures. (A) Bar graph indicating the percentage of nuclei that represents morphological
changes characteristic of apoptosis in MCF12A cells, (B) representative image of MCF12A cells stained with Hoechst, (C) bar graphs indicating the percentage of
nuclei that represents morphological changes characteristic of apoptosis in MDAMB231 cells, and (D) representative images of MDAMB231 cells stained with
Hoechst. Red arrows demonstrate apoptotic nuclear features. Each value represents the mean ± SEM of at least three independent determinations. Con, control;
*p < 0.05; **p < 0.01.
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FIGURE 2 | LC3 II and Beclin 1 protein levels in MCF12A and MDAMB231 cells treated with Dox. Representative western blots and bar graphs showing
densitometric representation of LC3-II and Beclin-1 protein levels in MCF12A (A) and MDAMB231 (B) cells. Each value represents the mean ± SEM of at least three
independent determinations. AU, arbitrary units; Con, control; *p < 0.05; **p < 0.01; ns, no significance.
there was a slight increase in beclin-1 expression in both cell lines,
these changes did not reach statistical significance.
Caspase Activity Increased Following
Treatment With Dox and Dox
Combinations
MCF12A cells displayed significantly increased caspase 3/7
activity following treatment with Dox for 24 h (Figure 3A).
MDAMB231 cells also displayed a more pronounced (and
significant) increase in caspase 3/7 activity following Dox
treatment (Figure 3B). ATG5 siRNA transfection was used to
inhibit autophagy. In MCF12A cells treated with Dox, ATG5
siRNA did not alter caspase 3/7 activity (Figure 3B), whereas
in MDAMB231 cells, ATG5 siRNA significantly increased
caspase 3/7 activity when administered in combination with
Dox (Figure 3E). No changes in caspase activity was observed
in either cell line when ATG5 siRNA was administered
alone (Supplementary Figure 1). Treating either MCF12A or
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FIGURE 3 | Caspase 3/7 activity in MCF12A and MDAMB231 cells following Dox treatment and autophagy inhibition. Caspase 3/7 activity in MCF12A cells following
treatment with Dox alone (A), in combination with ATG5 siRNA-mediated autophagy inhibition (B), and in combination with Baf-mediated autophagy inhibition (C).
Caspase 3/7 activity in MDAMB231 cells following treatment with Dox alone (D), in combination with ATG5 siRNA-mediated autophagy inhibition (E), and in
combination with Baf-mediated autophagy inhibition (F). Results represent fold change in luminescence in cultures incubated with Dox vs. untreated cells. Images
were obtained using a 10× objective with each value representing the mean ± SEM of at least three independent determinations. *p < 0.05; **p < 0.01;
***p < 0.001; #p < 0.05, ns, no significance.
MDAMB231 cells with Baf (10 nM) 6 h prior to analysis greatly
increased caspase 3/7 activity when these cells were also treated
with Dox (Figures 3C,F).
Baf Increased Detectable Levels of
Intracellular Dox in MCF12A and
MDAMB231 Cells Treated With Dox
Cells were stained with LAMP-2A during Dox treatment.
Intracellular localization of Dox was tracked by exploiting
the compound’s autofluorescence, a technique that has been
utilized successfully in MDAMB231 and other cell lines
(Li et al., 2010). MCF12A cells treated with Dox displayed
diffuse intracellular red fluorescence associated with Dox
(Figure 4A). Notably, small localized regions of intense red
fluorescence were observed in most Dox-treated MCF12A
cells (arrows), but were completely absent in cells that had
also been treated with Baf. MDAMB231 cells treated with
Dox displayed intense localized regions of intracellular red
fluorescence associated with Dox (Figure 4B). This red
fluorescence was associated with pooled punctate LAMP-2A
signal (arrows) in Dox-treated MDAMB231 cells. Notably,
LAMP-2A fluorescence appeared more diffuse if Baf was
added. Importantly, MDAMB231 cells treated with Dox
and Baf had significantly more observable red fluorescence
within the cytoplasmic regions of these cells. However, unlike
MCF12A cells, there was no Dox associated with the nuclear
regions of these cells.
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FIGURE 4 | Intracellular localization of LAMP-2A and Dox in Dox-treated MCF12A and MDAMB231 cells following autophagy inhibition. Representative images of
LAMP-2A staining (green) and Dox (red) within MCF12A (A) and MDAMB231 (B) cells in the presence of Dox alone or in combination with Baf. Arrows highlight
regions of localized Dox accumulation overlapping with regions of punctate LAMP-2A signal. Comparative control groups (cells treated with Dox in the presence of
amino acids) are shared between Figure 4 and Figure 7 since treatment groups from both figures were performed together in one experiment. Images were
obtained using a 40× objective.
Depleting Culture Medium of Amino
Acids During Dox Treatment Protects
MCF12A, but Not MDAMB231 Cells From
Apoptosis
Amino acid deprivation significantly decreased caspase 3/7
activity in MCF12A cells when treated with Dox for 24 h
(Figure 5A). This protection from increased caspase activation
corresponded with increased and sustained lysosomal acidity,
as measured with flow cytometry using cells stained with
Lysotracker (Figure 5C). This is in direct contrast to the results
obtained with MDAMB231 cells where incubation in culture
medium deprived of amino acids, during treatment with Dox,
resulted in significantly increased caspase 3/7 activity at 24 h
(Figure 5B2), but not 12 h (Figure 5B1) after intervention.
Amino acid deprivation during a 24 h treatment with Dox also
resulted in significantly diminished lysosomal acidity levels, close
to baseline, in MDABM231 cells (Figure 5D).
The trypan blue vital stain can traverse only cell membranes
with compromised integrity, and therefore functions as a marker
of necrotic and late stage apoptotic cell death and can be
used as an indicator of actual cellular impairment following an
intervention. MCF12A cells are extremely susceptible to Dox
cytotoxicity with approximately 80% of these cells becoming
trypan blue positive after a 24 h incubation with Dox (Figure 5E).
Treatment with Dox in culture medium completely depleted of
amino acids resulted in significantly less MCF12A cells becoming
trypan blue positive.
MDAMB231 cells appeared to be comparatively resistant
to Dox-induced membrane impairment, and amino acid
starvation did not change the percentage of trypan blue positive
MDAMB231 cells following treatment with Dox (Figure 5F).
Amino Acid Deprivation Increased
Autophagy Induction and Autophagy
Flux in MCF12A Cells
LC3-II decorates inner and outer membranes of autophagosomes
and is the only reliable marker to analyze autophagy flux
(Martinez-Lopez et al., 2016). Dox treatment during amino
acid deprivation resulted in increased induction of LC3 II in
MCF12A cells (Figure 6A). Furthermore, LC3 II protein levels
were shown to accumulate if Baf was administered 6 h prior to
analysis. Although a slight change was noticed in MDAMB231
cells when Baf was administered, this change was found to be
non-significant (Figure 6B).
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FIGURE 5 | The effect of amino acid starvation in MCF12A and MDAMB231 cells following Dox treatment. Caspase 3/7 activity in amino acid-starved MCF12A after
24 h (A) and MDAMB231 cells after 12 (B1) and 24 h (B2) following Dox treatment. Lysosomal acidity in amino acid-starved MCF12A (C) and MDAMB231 (D) cells
following Dox treatment. Trypan blue positive cell staining in amino acid-starved MCF12A (E) and MDAMB231 (F) cells following Dox treatment. Results represent
the fold change in cultures incubated with Dox vs. untreated cells. Cells were incubated in Dox and/or in amino acid deprived medium for 24 h where applicable.
Each value represents the mean ± SEM of at least three independent determinations. *p < 0.05; **p < 0.01; ***p < 0.001; #p < 0.05; ##p < 0.01; ###p < 0.001; ns,
no significance.
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FIGURE 6 | LC3 II protein levels during amino acid starvation in MCF12A and MDAMB231 cells. Representative western blots and Bar graphs showing
densitometric representations of LC3 II protein levels in MCF12A (A) and MDAMB231 (B) cells. Each value represents the mean ± SEM of at least three independent
determinations. AU, arbitrary units; *p < 0.05 vs. amino acid control; ns, no significance.
Amino Acid Deprivation or Autophagy
Inhibition With ATG5 siRNA During Dox
Treatment Resulted in Increased Levels
of Dox in the Nuclear Regions of
MDAMB231 Cells
Amino acid deprivation from culture medium during treatment
of MCF12A cells with Dox caused an apparent increase in
pooled punctate LAMP-2A in the perinuclear area of these cells
(illustrated by the arrow) (Figure 7A). Furthermore, amino acid
deprivation during treatment resulted in a prominent decrease
in observable Dox (red fluorescence). Inhibition of autophagy
with ATG5 siRNA resulted in a dispersed pattern of LAMP-2A
staining, but Dox was still readily visible in these cells.
MDAMB231 cells treated with Dox displayed intense localized
regions of LAMP-2A and intracellular red fluorescence associated
with each other (illustrated by the arrow) (Figure 7B). Amino
acid deprivation during treatment resulted in a more dispersed
staining pattern for the LAMP-2A marker. Furthermore, these
cells displayed increased levels of nuclear Dox (red fluorescence).
Inhibition of autophagy with ATG5 siRNA resulted in a
prominent increase in intracellular Dox, especially at the
perinuclear zone (illustrated by the arrow).
Amino Acid Deprivation During Dox
Treatment Exacerbated g2/m Cell Cycle
Arrest Associated With Dox Toxicity in
MDAMB231 Cells
Dox treatment of MCF12A cells resulted in significant changes
to the cell cycle profile. Deprivation of amino acids from culture
medium during treatment with Dox resulted in the percentage
of cells in the g0/g1 phase being similar to those in untreated
controls (Figure 8A). However, the percentage of cells in g2/m
phase decreased further if amino acids were absent.
Dox treatment is typically associated with an increased g2/m
arrest in MDAMB231 cells (Lambert et al., 2008), although
only a non-significant increase was observed in this specific
model (Figure 8B). Treatment of MDAMB231 cells with Dox
in culture medium deprived of amino acids resulted in a further
significant increase in the percentage of cells in the g2/m phase
of the cell cycle.
Amino Acid Deprivation Does Not Alter
Lysosomal Acidity or Apoptosis Levels
During Dox Treatment in Beclin 1
Haploinsufficient MCF7 Cells
MCF7 cells are autophagy incompetent due to a
haploinsufficiency in the gene coding for the autophagy
protein beclin 1 (Liang et al., 1999). Dox treatment, either with or
without amino acids, did not significantly alter lysosomal acidity
in these cells (Figure 9A). MCF7 cells do not express caspase 3
(Liang et al., 1999), which was confirmed by western blotting
analysis (Figure 9B). Dox treatment of MCF7 cells resulted in
increased apoptosis (Figures 9C,D). However, Dox treatment
of these cells in culture medium deprived of amino acids, either
with or without Baf, does not significantly alter apoptosis levels.
24 h Protein Starvation During High Dose
Doxorubicin (10 mg/kg) Treatment
Resulted in Increased Survival of E0771
Tumor-Bearing GFP-LC3 Mice
Mice with similar tumors and administered doxorubicin at a high
dose (10 mg/kg) on 2 days, either side of a day without treatment
had all died by day 12 after the initial treatment (Figure 10A). The
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FIGURE 7 | Intracellular localization of LAMP-2A and Dox in Dox-treated MCF12A and MDAMB231 cells following amino acid starvation and autophagy inhibition.
Representative images of LAMP-2A (green) straining and Dox (red) in MCF12A (A) and MDAMB231 (B) cells treated with Dox in culture medium without amino acids
or with ATG5 siRNA. Arrows highlight differences in localized signals of LAMP-2A and Dox. Comparative control groups (cells treated with Dox in the presence of
amino acids) are shared between Figure 4 and Figure 7 since treatment groups from both figures were performed together in one experiment. Images were
obtained using a 40× objective.
dose of doxorubicin was selected for acute exposure on the basis
of previous work that verified an inevitably toxic but not rapidly
fatal dose inducing myocardial damage, which is a common side-
effect of doxorubicin therapy (Sishi et al., 2013).
However, if tumor-bearing mice were placed on a diet free
of protein, immediately after i.p. injection with a high dose of
doxorubicin (10 mg/kg), then the survival of these mice was
prolonged compared to those fed a standard diet. Furthermore,
protein starved doxorubicin treated mice showed less signs of
reduced mobility and ruffled hair compared to mice treated
with doxorubicin but fed isocaloric protein complete diets
(data not shown).
24 h Protein Starvation During High Dose
Doxorubicin (10 mg/kg) Treatment Does
Not Influence Changes in Tumor
Volumes Attributed to Doxorubicin
Growth rates of E0771 tumors in GFP-LC3 mice were very
similar in size between groups, prior to the initial interventions
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FIGURE 8 | The effect of amino acid starvation and Dox treatment on the cells cycle of MCF12A and MDAMB231 cells. Representative DNA histograms and
quantified bar graphs of cell cycle progression in MCF12A (A) and MDAMB231 (B) cells. Cell cycle progression was assessed using flow cytometry. Each value
represents the mean ± SEM of at least three independent determinations. aacids, amino acids; *p < 0.05; **p < 0.01.
(Figure 10B). Administration of two high dose doxorubicin
(10 mg/kg) treatments over 3 days in GFP-LC3 mice bearing large
E0771 tumors (>230 mm2) resulted in significant reductions in
tumor size by day eight after the first intervention (Figure 10B).
If tumor-bearing mice were placed on diets free of protein during
doxorubicin treatment (10 mg/kg), reductions in tumor size were
shown to be similar to those treated with doxorubicin but fed
protein complete diets (Figure 10B).
24 h Protein Starvation During High Dose
Doxorubicin (10 mg/kg) Treatment
Results in Significantly Increased
Intratumour Autophagy Flux in E0771
Induced Tumors in GFP-LC3 Mice
Flow cytometry and FACS can be used to monitor autophagy
in cells containing GFP-LC3 by exploiting the fact that
GFP is sensitive to acidic environments, such as that of
lysosomes (Martinet et al., 2006; Yang et al., 2007), and
GFP fluorescence disappears immediately on it entering the
reduced pH environment of a lysosome. A reduction in GFP
signal therefore reflects delivery of the GFP-LC3 complex into
lysosomes and can be related to the degree of autophagy flux
(Shvets et al., 2008). Administration of two high dose doxorubicin
(10 mg/kg) treatments over 3 days in GFP-LC3 mice bearing
large E0771 induced tumors (>230 mm2) resulted in a significant
increase in GFP signal. This is inferred to indicate an increased
autophagy induction and translation of the GFP-LC3 complex
(Figure 10C). However, if mice were placed on a protein
free diet for 24 h at the start of their night cycle, beginning
immediately after each doxorubicin (10 mg/kg) injection, then a
significant decrease in GFP signal indicates a significant increase
in autophagy flux compared to mice treated but fed on protein
complete diets. As only non-cancer cells contain the GFP-LC3,
significantly increased intratumour autophagy flux implies that
there is an increased autophagy flux in non-cancer stromal cells
within the E0771 induced tumors of treated GFP-LC3 mice fed
protein free diets compared to those fed protein complete diets.
24 h Protein Starvation During High Dose
Doxorubicin (10 mg/kg) Treatment
Results in Significantly Lower Caspase
Activity Within Tumors
Administration of two high dose doxorubicin (10 mg/kg)
treatments over 3 days in GFP-LC3 mice bearing large E0771
induced tumors (>230 mm2) resulted in a significant increase
in caspase activity within whole excised tumors, using a
FLIVOTM (FLuorescence in vIVO) in vivo apoptosis tracer
(Immunochemistry Technologies LLC, MN, United States) and
FACS flow cytometry (Figure 10C). However, if mice were
placed on a protein free diet for 24 h at the start of their night
cycle, beginning immediately after each doxorubicin injection,
then caspase activity was observed to be significantly lower
in excised tumors than in those mice treated but fed on
protein complete diets.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 12 October 2020 | Volume 8 | Article 565915
fcell-08-565915 October 11, 2020 Time: 10:18 # 13
Thomas et al. Nutrient Starvation and Chemotherapy
FIGURE 9 | The effect of amino acid starvation, autophagy inhibition and Dox treatment in beclin 1-haploinsufficient MCF7 cells. (A) Lysosomal acidity in amino
acid-starved MCF7 cells following Dox treatment. (B) Representative western blot showing lack of caspase 3 expression in MCF7 cells. (C) Bar graph indicating the
percentage of nuclei that represents morphological changes characteristic of apoptosis in MCF7 cells following Dox treatment and Baf-mediated autophagy
inhibition and (D) representative images of MCF7 cells stained with Hoechst. Red arrows demonstrate apoptotic nuclear features. Images were obtained using a
10× objective. Each value represents the mean ± SEM of at least three independent determinations. + con, positive control; con, control; aacids, amino acids;
*p < 0.05 vs. amino acid control.
DISCUSSION
Many cancers are known to respond to certain
chemotherapeutics or to radiation therapy by increasing
autophagic activity. Although the consequences of autophagic
activation in these circumstances are still debatable, it appears
autophagy acts in its predominant role as survival mediator in
many of these cases (Yang and Chen, 2011). Anthracyclins such as
Dox have also been shown to increase autophagy levels in cancer
cells in some instances. At lower doses, Dox elicits an autophagic
response in breast cancer cells (Akar et al., 2008), as well as in
sarcoma cell lines (Martinez-Lopez et al., 2016). Additionally,
increased levels of ATG2A mRNA have been observed following
Dox treatment (Levy and Thorburn, 2011), suggesting increased
autophagy activation at the transcriptional level.
It was also reported that 2-deoxy-glucose preserved
ATP content and contributed to the cytoprotection of rat
cardiomyocytes treated with 1 µM Dox (Chen et al., 2011). This
glucose analogue increased markers of autophagy which was
posited as a potential reason for protection from cytotoxicity.
Conversely, activation of autophagy in cultured cardiomyocytes
following 1 µM Dox treatment mediated its cardiotoxic effect
(Kobayashi et al., 2010). Here, it was shown that autophagy
inhibition resulted in decreased cell death and it was postulated
that autophagy directly contributed to Dox-induced toxicity.
These exemplify the conflicting nature of studies and reported
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FIGURE 10 | The effect of 24 h protein starvation during high dose doxorubicin (10 mg/kg) treatment on survival and tumor growth of E0771 tumor-bearing mice.
Mice received two i.p. injections of doxorubicin (10 mg/kg) over a period of 3 days and were placed on either a isocaloric diet or a diet free of protein for a total 24 h
immediately following each doxorubicin administration. (A) Survival of tumor-bearing mice following doxorubicin treatment with or without protein starvation, N = 6.
(B) Changes in tumor volumes of tumor-bearing mice following doxorubicin treatment with or without protein starvation, N = 6. Values are expressed as
mean ± SEM. *p < 0.05 untreated control vs. doxorubicin and vs. doxorubicin + protein free diet. (C) Intratumour autophagy flux in GFP-LC3 mice following
doxorubicin treatment with or without protein starvation. A decrease in GFP signal indicates increased autophagy flux. N = 3. Values are expressed as mean ± SEM.
*p < 0.05 vs. untreated + protein diet. #p < 0.05. (D) Intratumour caspase cleavage in GFP-LC3 mice following doxorubicin treatment with or without protein
starvation. FLIVOTM caspase dye was used to assess caspase cleavage, with increased fluorescence indicating cleavage. N = 3. Values are expressed as
mean ± SEM. *p < 0.05 vs. + protein diet. *p < 0.05; #p < 0.05; ns, no significance.
FIGURE 11 | Graphical Summary. Proposed model for differential toxicity in normal breast epithelial cells and breast cancer cells.
findings relating autophagy to drug toxicity and illustrate the
need for further research into this important topic.
Autophagy activity is increased in response to stress, where
it functions as an important mechanism whereby damaged
organelles and aggregated proteins are degraded in lysosomes.
However, there is still no clear mechanism whereby induction
of autophagy could lead to tolerance against chemotherapy
agents. Lysosomal fusion and throughput of autophagy depends
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on the low pH of lysosomal compartments (Klionsky et al.,
2008). Increasing the lysosomal pH with pharmacological agents
is an effective method of autophagy inhibition, as disruption
of the fusion event between autophagosomes and lysosomes
prevents progression of autophagy. Some drug resistant cell lines
are able to tolerate alkaline chemotherapy drugs such as the
anthracyclines by sequestering and deactivating these agents in
the acidic compartments of lysosomes (Hurwitz et al., 1997).
Exposure of these compounds to environments of low pH
renders them inactive and unable to access sites of chemotoxicity
such as the nucleus.
Data from the current study clearly indicated that the
non-tumourigenic cell line MCF12A is more susceptible to
programmed cell death during treatment with a moderate
dose of Dox (1 µM) than the metastatic breast cancer cell
line MDAMB231. MCF12A cells had a significantly increased
appearance of morphological changes characteristic of apoptosis
(Figure 1A), as well as significantly enhanced caspase 3/7 activity
(Figure 3A). On the other hand, MDAMB231 cells showed
few signs of late stage apoptosis and a more modest increase
in activation of caspase 3/7 (Figures 1B, 3D). Interestingly,
depletion of amino acids from the culture medium of MCF12A
cells during Dox treatment resulted in a significant protection
from loss of membrane integrity (a sign of late stage cell damage),
as assessed by the trypan blue assay (Figure 5E). Previous
experimental data revealed that amino acid starvation resulted
in an enhanced autophagy response (unpublished from this
group). It is suggested here that this increase in autophagy
could be responsible, at least in part, for the tolerance to Dox
treatment seen here. On the other hand, MDAMB231 cells did
not experience any protection if starved of amino acids during
treatment (Figure 5F).
Both MCF12A and MDAMB231 cells responded to the
presence of Dox (1 µM) by increasing LC3 II protein levels
(Figure 2), indicating an autophagic response during treatment.
A slight increase in beclin 1 protein expression was also observed,
however, these changes were not statistically significant. While
beclin 1 plays an important role in the regulation of autophagy,
it is also cleaved by caspase 3 during apoptosis (Wirawan et al.,
2010). Since apoptosis was induced under these conditions,
it may have resulted in varying levels of detectable beclin 1
protein expression and thus the lack of a significant effect.
Inhibition of autophagy with ATG5 siRNA lead to a significant
increase in caspase 3/7 activity only in MDAMB231 cells
(Figure 3E), suggesting that autophagy has a protective role
during chemotherapy of these cells. Importantly, the addition
of Baf, 6 h prior to analysis, greatly increased caspase 3/7
activity during Dox treatment in both cell lines (Figures 3C,F),
but had a particularly pronounced influence on the resistant
cancer cell line. The differential effects displayed between ATG5
siRNA and Baf treatment in these cell lines might be due
to the fact that Bafilomycin represents a mechanism of late-
stage autophagy inhibition, while ATG5 knockdown facilitates
autophagy inhibition at an earlier stage. Agents such as Baf, a
specific inhibitor of vacuolar H+ATPase (V-ATPase) (Klionsky
et al., 2008), are known to rapidly and reversibly inhibit fusion
between autophagosomes and lysosomes, if administered for
short time periods (Chen et al., 2011), through the mechanism
of inhibiting lysosomal acidification (Hurwitz et al., 1997).
Furthermore, many drug resistant cancer cells are thought
to increase sequestration and deactivation of chemotherapy
drugs within lysosomes (Kobayashi et al., 2010). The proposed
mechanism is through increased uptake of these compounds
into endosomes, which eventually fuse with lysosomes to deliver
these drugs into the acidic internal environments where they
become deactivated (Wirawan et al., 2010). Baf and other
agents that raise the pH of lysosomes can increase cytotoxicity
by preventing fusion and inactivation of drugs in this way.
Therefore, the increased caspase activity observed in the current
study, following Baf administration, suggested that Baf prevented
the sequestration and deactivation of Dox, therefore allowing
Dox to exert its cytotoxic effects on the cell. As autophagy
inhibition also resulted in increased caspase activity here, it is
possible that mass engulfment of cytoplasmic material (which
includes Dox) could facilitate delivery of this drug into lysosomal
compartments in this cell line and thereby have a protective
influence. As MDAMB231 cells have high basal autophagy levels
(unpublished data), internalized Dox could be rapidly delivered
to lysosomes and deactivated, conferring a partial resistance.
These assertions are further strengthened by qualitative
evidence gained from fluorescence microscopy of MDAMB231
cells receiving Dox treatment. Intracellular localization of Dox
can be tracked by exploiting the autofluorescence of Dox, a
technique that has been utilized successfully in MDAMB231 and
other cell lines in the past (Yoshimori et al., 1991). Treatment
of MDAMB231 cells resulted in the clear accumulation of
Dox at perinuclear regions (Figure 4B). Identification of the
localization of lysosomes at the same time, by fluorescently
tagging the lysosomal associated membrane protein LAMP-
2A, demonstrates lysosomal accumulation in regions associated
with Dox accumulation in these cells. This implies that Dox is
located in association with lysosomes during these conditions.
MCF12A cells show little accumulation of Dox after a 24 h
treatment and have no discernible accumulation of LAMP-
2A signal (Figure 4A). Furthermore, the addition of Baf 6 h
prior to imaging, led to a vast and pronounced accumulation
of Dox within the cytoplasmic compartment of MDAMB231
cells. Interestingly, accumulation of the LAMP-2A signal is
mostly dissipated and little association between LAMP-2A
and Dox was evident after the addition of Baf. Therefore,
it appears as though Dox is not associated with lysosomes
when administered in the presence of the vacuolar H+ATPase
inhibitor Baf, but rather elsewhere within the cell. As Baf inhibits
the fusion of autophagosomes and endosomes with lysosomes
(Hurwitz et al., 1997; Chen et al., 2011), it is possible that the
observed accumulations of Dox is due to increased cytoplasmic
accumulation of autophagosomes and endosomes containing
Dox, but which are unable to fuse with lysosomes. Further
investigation of this phenomenon is required.
Autophagic flux is clearly increased in MDAMB231 cells in
response to Dox treatment (Figure 6), and lysosomal acidity
greatly increased as a result of this treatment in both MCF12A
cells (Figure 5C) and in MDAMB231 cells (Figure 5D).
Interestingly, when these cell lines were treated with Dox in
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culture medium deprived of amino acids, lysosomal acidity
significantly decreased in MDAMB231 cells, but remained
elevated in MCF12A cells. Notably, alterations in lysosomal
acidity were associated with corresponding changes in caspase
3/7 activity in both cell lines (Figures 5A,D). MDAMB231 cells
experienced significantly greater levels of caspase 3/7 activity
during conditions of depressed lysosomal acidity, while MCF12A
cells were granted a relative protection from the cytotoxic
impact of drug treatment. Strikingly, if MDAMB231 cells were
analyzed after 12 h of combined Dox/amino acid starvation
treatment, these increases in apoptosis activation were not
evident. Importantly, at this time point of amino acid starvation
lysosomal acidity was confirmed to be elevated compared to
baseline (unpublished data), further supporting the premise of
lysosomal acidity deprivation facilitated increases in caspase
activity in this model.
If decreased lysosomal acidity levels during amino acid
starvation prevent fusion of autophagosomes with lysosomes
then the probability of drug access to sites of cytotoxic action
would be increased. This would result in the increased apoptosis
activation demonstrated here. Dox treatment is associated with
genotoxic stress and prolonged g2/m cell cycle arrest (Yamamoto
et al., 1998), due to intercalation of this agent with DNA and
activation of the g2/m DNA damage checkpoint. Therefore,
decreased abundance of Dox within lysosomes during amino
acid deprivation would result in an exacerbated accumulation
of cells in the g2/m phase of the cell cycle. Our experimental
data supports this with an approximately 6% increase in the
percentage of MDAMB231 cells in the g2/m phase of the
cell cycle if Dox treated cells are simultaneously starved of
amino acids (Figure 8B). Additionally, the relative protection of
MCF12A cells can be attributed to increased autophagy levels and
decreased access of Dox to the nucleus, as amino acid starvation
during drug treatment resulted in a cell cycle profile similar to
that of untreated cells (Figure 8A). Also, qualitative experimental
evidence shows that Dox treatment during amino acid starvation
causes decreased Dox and LAMP-2A accumulation and an
increased Dox signal in the nuclear regions of MDAMB231 cells
(Figure 7B), whereas the opposite is observed in MCF12A cells
during similar treatment (Figure 7A).
Data suggested that alterations in lysosomal acidity are linked
to increased apoptosis induction or protection in MDAMB231
cells and MCF12A cells, respectively. However, the role for
autophagy should not be overlooked. Inhibition of autophagy
with ATG5 siRNA resulted in a prominent increase in levels of
Dox in the nucleus and at the perinuclear zone in MDAMB231
cells (Figure 7B), while MCF12A cells exposed to ATG5
siRNA prior to treatment showed signs of increased cytoplasmic
Dox accumulation (Figure 7A). Interestingly, a cell line with
decreased autophagy (MCF7), due to haploinsufficiency in the
gene coding for beclin 1, displayed no alterations in lysosomal
acidity during Dox treatment, in the presence or absence of
amino acids (Figure 9A). While this cell line does not possess
active caspase 3 (Figure 9B), it did show signs of significantly
increased apoptosis during Dox treatment. These levels of
apoptosis did not increase if treatment occurred in the absence
of amino acids or the presence of Baf (Figures 9C,D). Together,
these results indicate that active autophagic machinery is required
for the accumulation of Dox within lysosomes and demonstrated
an important role for autophagy in these processes. As interest
in modulation of autophagy during cancer treatment increases
and novel strategies such as fasting therapy during high-dose
cancer treatment are explored, it is imperative that studies be
undertaken to understand the underlying mechanisms driving
these beneficial effects before use begins in a clinical setting.
Therefore, in this part of the study we aimed to determine the
effect of short-term protein starvation in mice receiving a high
cumulative dose of doxorubicin treatment. Using a mammary
tumor model, it was shown that high-dose doxorubicin treatment
(10 mg/kg for a cumulative dose of 20 mg/kg over 3 days) resulted
in low survival rates of rodents possessing large, aggressive
tumors (Figure 10A). Remarkably, survival was significantly
improved if mice were placed on protein free diets immediately
after drug administration (Figure 10A). Although evidently
extremely toxic to the tumor-bearing mice in this model, the dose
of doxorubicin used here was sufficient to significantly reduce
tumor size after only 8 days. However, these reductions in tumor
sizes were not diminished in those mice starved of proteins
during treatment (Figure 10B).
Since our in vitro experimental data has shown that while a
non-cancer cell line experienced protection if starved of amino
acids during doxorubicin treatment, a cancer cell line with
high basal autophagy activity had increased cell death. We have
therefore utilized our GFP-LC3 tumor-bearing mouse model to
assess the impact of protein starvation on autophagy flux in the
host derived stromal subpopulation within the mammary tumors
of mice treated with doxorubicin. We have shown an increase in
intratumour autophagic flux in the non-cancer cell population
of these tumors (Figure 10C). Interestingly, this increase in
autophagy flux in the tumor stromal subpopulation correlated
with a decrease in intratumour apoptosis (Figure 10D).
Cancers are extremely heterogenous by nature and much of
their volume can be comprised of non-cancer cells that are vital
for their continued growth and development (Lee and Tannock,
2006). As solid tumors rely on non-cancer cells for survival,
any protection of these cells from cytotoxicity during short term
starvation could indirectly result in prolonged tumor cell survival
during chemotherapy. Also, the benefits of fasting in cellular
protection from cytotoxicity may rely partly on altered circulating
hormone levels (Li et al., 2010), which necessitates further
investigation using in vivo models. In fact, reduced circulating
IGF-I levels have been implicated in the differential protection
of normal cells and cancer cells in response to fasting and
improved chemotherapeutic index during doxorubicin treatment
(Koutsilieris et al., 1999).
Our cell culture based studies demonstrated a promising
differential protection of non-cancer cells and increased signs
of apoptosis in cancer cells during chemotherapy when
these cell lines were starved of amino acids (Figure 11).
However, translation of this model in vivo has shown that
although protein deprivation appears to increase survival
rates without impacting on reductions in tumor volumes
during high dose doxorubicin treatment, a potentially increased
protection may be occurring in cells within these tumors.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 16 October 2020 | Volume 8 | Article 565915
fcell-08-565915 October 11, 2020 Time: 10:18 # 17
Thomas et al. Nutrient Starvation and Chemotherapy
The model established here, and the related findings, have
presented a novel and unique platform for further research
into this remarkable phenomenon, and particularly the role of
autophagy therein.
This data represents a caveat to researchers aiming to utilize
fasting or starvation diets in combination with conventional
chemotherapy, and illustrates that additional mechanistic
data is required in order to better understand the indirect
consequences of such treatment strategies. Together with the
in vitro experimental data, these promising findings imply
a role for autophagy in the differential protection during
doxorubicin treatment.
CONCLUSION
The results of this study suggest that the inherent resistance to the
alkaline chemotherapeutic agent Dox exhibit by the MDAMB231
cells can be attenuated by elevating the lysosomal pH in a
pharmacological manner. Furthermore, short term amino acid
starvation was shown to be a realistic avenue for adjuvant
therapy since it strengthened the cytotoxic effect of Dox in
the MDAMB231 cancer cells but not in the normal MCF12
cells. Non-cancerous cells were potentially protected from the
anthracycline due to the ability to increase autophagic activity in
response to short term amino acid starvation.
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